Puma Biotechnology | PBYI - Adi Hisse Senedi Sermaye





Adi Hisse Senedi Sermaye Değişiklik Tarih
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amgen USD 540M 1000K 2026-03
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Daiichi Sankyo JPY 1.85B 9K 2025-12
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Exelixis USD 262.48M 5.61M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Incyte USD 199.95M 1.49M 2026-03
MacroGenics USD 63.32M 60K 2025-12
Moderna USD 391M 2M 2025-09
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.69B 0 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.6M 158K 2025-12
Vanda Pharmaceuticals USD 58K 0 2024-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03